Esther K Choo1,2,3, Caron Zlotnick4,5, David R Strong6, Daniel D Squires3, Chantal Tapé1, Michael J Mello2,3. 1. a Division of Sex and Gender in Emergency Medicine, Department of Emergency Medicine, Warren Alpert Medical School of Brown University , Providence , Rhode Island , USA. 2. b Injury Prevention Center, Department of Emergency Medicine, Warren Alpert Medical School of Brown University , Providence , Rhode Island , USA. 3. c Brown University School of Public Health , Providence , Rhode Island , USA. 4. d Department of Psychiatry and Human Behavior , Brown University , Providence , Rhode Island , USA. 5. e Department of Psychiatry and Mental Health , University of Cape Town , Cape Town , South Africa. 6. f Division of Behavioral Medicine, Department of Family Medicine and Public Health, University of California , San Diego , California , USA.
Abstract
BACKGROUND: Addressing violence along with drug use change goals is critical for women with coexisting intimate partner violence (IPV) and substance use disorders (SUDs). METHODS: This was an acceptability and feasibility study of BSAFER, a brief Web-based program and booster phone call addressing violence and drug use. A screening survey identified women with recent drug use and IPV in the emergency department (ED). Participants were randomized to BSAFER or a Web-based control program and booster call providing education about home fire safety. Program completion, usability, satisfaction, and motivational interviewing (MI) adherence were primary outcomes. Drug use and IPV outcomes were measured at baseline, 1 month, and 3 months. RESULTS:Forty women were enrolled (21 BSAFER, 19 control); 50% were nonwhite and mean age was 30 years. The most commonly used drugs were marijuana (88%) and cocaine (30%); 45% reported physical abuse, and 33% reported severe combined physical and sexual abuse. Thirty-nine (98%) completed the Web program, 30 (75%) completed the booster, and 29 (73%) completed the 3-month follow-up. Mean System Usability Scale (SUS) for the BSAFER Web program was 84 (95% confidence interval [CI]: 78-89) of 100; mean Client Satisfaction Questionnaire (CSQ-8) was 28 (95% CI: 26-29) of 32. MI adherence scores were high and similar for both the Web program and the booster. Both intervention and control groups had small mean decreases in weekly drug use days (0.7 vs. 1.5 days); participants using drugs other than marijuana demonstrated greater average reductions in drug use than those using marijuana only. CONCLUSIONS: An ED Web-based intervention for SUDs and IPV in women demonstrated feasibility and acceptability. Future studies will examine efficacy of the BSAFER program and investigate whether specific subgroups of drug using women may be most responsive to ED-based Web interventions.
RCT Entities:
BACKGROUND: Addressing violence along with drug use change goals is critical for women with coexisting intimate partner violence (IPV) and substance use disorders (SUDs). METHODS: This was an acceptability and feasibility study of BSAFER, a brief Web-based program and booster phone call addressing violence and drug use. A screening survey identified women with recent drug use and IPV in the emergency department (ED). Participants were randomized to BSAFER or a Web-based control program and booster call providing education about home fire safety. Program completion, usability, satisfaction, and motivational interviewing (MI) adherence were primary outcomes. Drug use and IPV outcomes were measured at baseline, 1 month, and 3 months. RESULTS: Forty women were enrolled (21 BSAFER, 19 control); 50% were nonwhite and mean age was 30 years. The most commonly used drugs were marijuana (88%) and cocaine (30%); 45% reported physical abuse, and 33% reported severe combined physical and sexual abuse. Thirty-nine (98%) completed the Web program, 30 (75%) completed the booster, and 29 (73%) completed the 3-month follow-up. Mean System Usability Scale (SUS) for the BSAFER Web program was 84 (95% confidence interval [CI]: 78-89) of 100; mean Client Satisfaction Questionnaire (CSQ-8) was 28 (95% CI: 26-29) of 32. MI adherence scores were high and similar for both the Web program and the booster. Both intervention and control groups had small mean decreases in weekly drug use days (0.7 vs. 1.5 days); participants using drugs other than marijuana demonstrated greater average reductions in drug use than those using marijuana only. CONCLUSIONS: An ED Web-based intervention for SUDs and IPV in women demonstrated feasibility and acceptability. Future studies will examine efficacy of the BSAFER program and investigate whether specific subgroups of drug using women may be most responsive to ED-based Web interventions.
Entities:
Keywords:
Computers; domestic violence; drug use disorders; emergency medicine; intervention studies; women's health
Authors: Maureen A Walton; Stephen T Chermack; Jean T Shope; C Raymond Bingham; Marc A Zimmerman; Frederic C Blow; Rebecca M Cunningham Journal: JAMA Date: 2010-08-04 Impact factor: 56.272
Authors: Richard Saitz; Tibor P A Palfai; Debbie M Cheng; Daniel P Alford; Judith A Bernstein; Christine A Lloyd-Travaglini; Seville M Meli; Christine E Chaisson; Jeffrey H Samet Journal: JAMA Date: 2014-08-06 Impact factor: 56.272
Authors: Sarah A Pollick; Jessica R Beatty; Robert J Sokol; Ronald C Strickler; Grace Chang; Dace S Svikis; Golfo K Tzilos; Steven J Ondersma Journal: Subst Abus Date: 2015-01-13 Impact factor: 3.716
Authors: Amber L Hill; Hadas Zachor; Kelley A Jones; Janine Talis; Sarah Zelazny; Elizabeth Miller Journal: J Womens Health (Larchmt) Date: 2019-04-10 Impact factor: 2.681
Authors: Wenhao Dai; Ryan Palmer; Aashna Sunderrajan; Marta Durantini; Flor Sánchez; Laura R Glasman; Fan Xuan Chen; Dolores Albarracín Journal: Psychol Addict Behav Date: 2020-04-20
Authors: Brian J Biroscak; Michael V Pantalon; James D Dziura; Denise P Hersey; Federico E Vaca Journal: Subst Abus Date: 2019-03-04 Impact factor: 3.716
Authors: Ruhee Shah; Alessandra Della Porta; Sherman Leung; Margaret Samuels-Kalow; Elizabeth M Schoenfeld; Lynne D Richardson; Michelle P Lin Journal: West J Emerg Med Date: 2021-10-27